See also this year's filing and all EDGAR filings for this company.
PDF Report 0001316175_2018_Anthera_Pharmaceuticals_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('EntityCommonStockSharesOutstanding')"} |
Graph
Absolute values for 0001316175, Anthera Pharmaceuticals Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 3,191,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 482,000 |
| 3 | remainder_Assets | 0 |
| 4 | LiabilitiesCurrent | 4,711,000 |
| 5 | LiabilitiesNoncurrent | 4,457,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 7,938,000 |
| 9 | ResearchAndDevelopmentExpense | 28,594,000 |
| 10 | remainder_Expenses | -100,000 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 9,558,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 3,673,000 |
| 1 | Liabilities | 9,168,000 |
| 2 | Expenses | 36,432,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | -5,495,000 |
| 5 | NetIncome | -26,874,000 |
| 6 | ComprehensiveNetIncome | -26,874,000 |
| 7 | BaseVar | 29,415,500 |
| 8 | EconomicCapitalRatio | -5.66 |
Edgar->Model Mapping
Feature Distribution
Change over Time
